EWM
FSTX

Evercore Wealth Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Evercore Wealth Management’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-250
Closed -$13K – 843
2017
Q4 		$13K Hold
250
– – ﹤0.01% 785
2017
Q3 		$17K Hold
250
– – ﹤0.01% 737
2017
Q2 		$14K Buy
+250
New +$11.6K ﹤0.01% 776

Other funds holding FSTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $481M AUM 46% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Evercore Wealth Management's FSTX Position: Q1 2018 in Review

Evercore Wealth Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2018, closing a stake of 250 shares — an estimated $13K sold.

Evercore Wealth Management first reported a position in FSTX in Q2 2017 and held it in 3 quarters. The position peaked at $17K in Q3 2017. 39 funds tracked by Wall St. Rank hold FSTX as of Q1 2018.

  • Evercore Wealth Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Evercore Wealth Management sold 250 F-star Therapeutics, Inc. Common Stock shares in Q1 2018, an estimated $13K.
  • Evercore Wealth Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2017 and held it in 3 quarters.
  • Evercore Wealth Management's F-star Therapeutics, Inc. Common Stock position peaked at $17K in Q3 2017.
  • 39 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2018.

Based on Evercore Wealth Management's 13F filing for Q1 2018, filed 15 May 2018.